AI Verdict
MED has stronger fundamentals based on our AI analysis.
MEHA vs MED Fundamental Comparison
| Metric | MEHA | MED |
|---|---|---|
| Revenue | $6.6M | $385.8M |
| Net Income | $758,478.0 | $-18.7M |
| Net Margin | 11.5% | -4.8% |
| ROE | 49.2% | -9.4% |
| ROA | 8.3% | -7.5% |
| Current Ratio | 0.90x | 4.69x |
| Debt/Equity | 0.09x | 0.00x |
| EPS | $0.01 | $-1.70 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MEHA vs MED: Frequently Asked Questions
Is MEHA or MED a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MED has stronger fundamentals. MEHA is rated SELL (75% confidence) while MED is rated SELL (85% confidence). This is not investment advice.
How does MEHA compare to MED fundamentally?
Functional Brands Inc. has ROE of 49.2% vs MEDIFAST INC's -9.4%. Net margins are 11.5% vs -4.8% respectively.
Which stock pays higher dividends, MEHA or MED?
MEHA has a dividend yield of N/A or no dividend while MED has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MEHA or MED for long term?
For long-term investing, consider that MEHA has SELL rating with 75% confidence, while MED has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MEHA vs MED?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MEHA vs MED, the AI consensus favors MED based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.